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ABSTRACT : Simultaneously two independent tumors were detected in the 
esophagus. Histological examination could not necessarily distinguish the two tumors 
from double cancers. It is emphasized that cellular DNA analysis by using FCM is of 
great benefit for this purpose. 
 It is difficult to determine clinically whether double cancers are simultaneously existing 
two cancers or cancerous lesion accompanying metastatic lesions. Until recently histologic 
finding was the only method to identify them. The criteria of identifying double cancers 
from primary cancer with metastasis are that different types of histology should be 
individually revealed and no histologic sequence between both. lesions should be defined 
with or without submucosal lymphatic involvement. 
 It is well known that malignant tumors are characterized by abnormalities in cellular 
DNA content. However, it is no doubt that metastatic tumors arising from the primary 
one display a similar pattern of DNA, suggesting identical stem cells with an original 
tumor when surgeons encounter in independent cancerous lesions in the same surgical 
specimen, two separated cancerous lesions should be identified whether double primary 
cancers or metastasis. 
 Flow cytometry (FCM) provides a fast and precise means for determination of 
DNA-aneuploidy index. 
 we experienced with independent double cancerous lesions in the esophagus and these 
were regarded as primary cancer with skipping metastatic lesions with the help of analysis 
of DNA histogram.
         PATIENTS 
 A 60-year-old man complained of dysphagia 
since May 1989 and this symptom was aggra-
vated in October with body weight loss of 5kg. 
Precise examination revealed a diagnose of 
carcinoma of the esophagus. On his admission, 
he could not take solid food, and his nutritional 
condition was poor. Immediately after his 
admission, total parental nutrition was initiated.
Radiological X-ray film showed the serratus type 
in the upper portion of the thoracic esophagus 
with 4cm shadow of a defect, and the other 
deformity was observed 3cm distal to the 
proximal lesion (Fig. 1). Endoscopic examina-
tion revealed circular stenosis 16cm distal to an 
incisor line, and an endoscopic tube was unable 
to pass through the stenotic lesion (Fig. 2). 
Therefore, the distal lesion could not be defined 
through the endoscopic tube. CT scan showed 
no direct invasion to the aoric and bronchial
Fig. 1. Radiological X-Ray film of esophagogram, 
      showing the abnormal findings of upper 
      and middle portion of thoracic esophagus.
Fig. 2. Endoscopic finding, showing the circular 
       stenosis which was unable to pass through 
       forwards.
Fig. 3. CT scan, showing the tumor mass of the esophagus, identifying no direct involvement 
      of the adjacent argan.
walls and also illustrated swelling in the 
subcarinal and paraesophageal nodes (Fig. 3). 
Right thoractomy was made to expose the 
esophagus. The tumor was situated in the 
middle portion of the esophagus with adventitial
invasion. Proximal lesion was resected with an 
additional resection. However, there was no 
direct involvement of the adjacent organs. The 
other lesion was not palpated through the 
esophageal wall. After subtotal esophagectomy,
Fig. 4. Surgical specimen, showing independent two cancerous lesion, which include the 
      proximal lesion in the additional resection specimen.
Fig. 5. Schema of the surgical specimen and DNA ploidy patterns in the corresponding 
      sites.
reconstruction was performed with gastric tube 
via retrosternal route at the neck. 
 The surgical specimen showed independent, 
two ulcerative lesions with healthy mucosa in 
3cm distance (Fig. 4, 5). These two ulcers were 
of irregular margins with interrupted mucosal 
folds. Histologic examination clarified squa-
mous cell carcinoma with poor differentiation 
in the both lesions involving the adventitia. The
proximal lesion was characterized by the finding 
of that was protruded with lymph vascular 
invasion, which was compatible with a metas-
tatic lesion. 
 However, it was not confirmable for the 
proximal lesion to be metastatic. Therefore, 
DNA analysis by FCM was applied for differentia-
tion of double cancers. 
 Paraffin-embedded tissues were cut into 40,um
sections and dewaxed with xylene, rehydrated 
with ethanol and incubated overnight at 37CC 
in trypsin citrate buffer, before staining with 
trypsin, trypsin inhibitor (RNase) and pro-
pidium iodide, spermine tetrahydrochloride. 
Finally fluorescence measurement was made by 
using FACS IV. 
 DNA histogram showed a similar pattern in 
the both ulcerative lesions on the condition of 
2.0 to 2.9 of CV. The DNA index indicated a 
range of 1.60 to 1.62 where DNA histogram in 
the separated healthy mucosa 2cm distal to the 
lesion showed a different patteren from those 
in the lesions which was regarded normal. 
 This was sufficient to infer that two inde-
pendent lesions were arising from the same stem 
cells that one was primary and the other was 
metastatic.
         DISCUSSION 
 FCM study is now prevalent as a clinical 
approach and aimes at obtaining additinal 
information in terms of tumor biology or 
prognosis. Furthermore, FCM provides a fast 
and precise determination in association with 
heterogeneity and different cellular clones of the 
tumors. 
 The two cancerous lesions existing. in the 
same surgical specimen should be suspected 
whether there exist double cancers or metastasis. 
 The criteria to determine synchromous double 
cancers were cytomorphologically clarified by 
many researchers in various organ. The clear 
definitions of double cancers are that different 
histologic patterns should be observed and 
arising from a different tissue origin as reported 
by Billoth') and Warren, Gatez). 
 In general, it is kept constant between 
chromosom number and cellular DNA in living 
tissues and these cells are considerated as being 
a stem cell associated with proliferation. 
 On the other hand, it is believed that the 
tumors pose inherent cellular DNA'-') in 
accordance with stem line theory'). 
 In the case with identical DNA pattern on 
histogram, it indicates that the tumors origi-
nates from the same clonal origin each other. 
 Scott') reported that cellular DNA analysis 
by FCM was of great benefit to determine
double cancers or metastasis. 
 On the contrary, Peterson') pointed out that 
31% of colon cancers showed a presence of 
mosaicism, as defined by the presence of a 
variety of cellular DNA content. Therefore, in 
analysis of cellular DNA the same pattern 
obtained on histogram imply a neoplasm arising 
from an identical stem cell. However, it is 
considered that multiclonarity may be underes-
timated if it is defined by the required presence 
of two aneuploid DNA stemlines because one 
of the tumor stemlines in a multiclonal tumor 
may be diploid and thus hidden within a peak 
of normal diploid cells. Furthermore, the 
presentation of multiclonality seems to reflect 
multifocal carcinogenesis, characteristic for 
certain tumor types (colon, small cell carcinoma 
of the lung) rather than changes during evolu-
tion of the tumor. Cellular DNA analysis by 
FCM is of clinical value to determine whether 
double cancers are presented or not in two 
independent tumors.
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